Portfolio company
XS Innovations
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops implantable vascular access valves for patients with end-stage kidney disease to reduce complications during and between haemodialysis sessions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
VenoStent
This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.
Healionics
Healionics produces synthetic vascular grafts for dialysis patients to improve blood access and reduce complications such as infection and occlusion.
Laminate Medical Technologies
This company develops an external support device to improve fistula success for hospitals and clinicians treating patients requiring dialysis.
Sonavex
This medical technology company develops automated ultrasound devices and bioresorbable markers for dialysis clinics and surgical teams to monitor vascular access and blood flow.
VASCULAR THERAPIES
This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.
ENDOVASCULAR DEVICES
This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.
V-Wave
This company develops implantable interatrial shunts to regulate heart pressure and reduce hospitalisations for patients suffering from chronic heart failure.
VasoNova
This company develops catheter navigation technology to guide and place vascular access devices for medical professionals and patients.
